6 assets in Diabetic Kidney Disease

Therapeutic assets addressing Diabetic Kidney Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Spironolactone Diabetic Kidney Disease	Hospital de Messejana Dr. Carlos Alberto Studart Gomes	P4	BB (65)
Finerenone Diabetic Kidney Disease	Hospital de Messejana Dr. Carlos Alberto Studart Gomes	P4	B (62)
Mitapivat Diabetic Kidney Disease	Agios Pharmaceuticals, Inc.	P2	CCC (53)
Iohexol Diabetic Kidney Disease	University of Colorado, Denver	P1/2	CCC (52)
Sodium P-Aminohippurate Diabetic Kidney Disease	University of Colorado, Denver	P1/2	CCC (52)